Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release ##### Up next ###### [Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition](https://thailandbusinessnews.net/press-release/menarini-group-announces-new-data-on-elzonris-tagraxofusp-erzs-to-be-presented-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition/) Published on 24 November 2025 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/2689936/5639737/Alzheimers_Association_Logo.jpg?p=medium600 "logo") – Results Underscore Need for Continued Research and Diverse Treatment Pipeline CHICAGO, Nov. 24, 2025 /PRNewswire/ — The Alzheimer’s Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically significant reduction in Alzheimer’s disease progression. [The studies](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4565580-1&h=1788874425&u=https%3A%2F%2Fwww.novonordisk.com%2Fcontent%2Fnncorp%2Fglobal%2Fen%2Fnews-and-media%2Fnews-and-ir-materials%2Fnews-details.html%3Fid%3D916462&a=The+studies) tested an oral semaglutide pill for the treatment of early-stage symptomatic Alzheimer’s disease. "While these results are not what we had hoped for, they will contribute to our understanding of this devastating and fatal disease," said [Joanne Pike, DrPH](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4565580-1&h=2239904923&u=https%3A%2F%2Fwww.alz.org%2Fabout%2Fleadership%2Fsenior_management%2Fjoanne_pike_dr_p_h&a=Joanne+Pike%2C+DrPH), Alzheimer’s Association president and chief executive officer. "The data from every clinical trial, regardless of outcome, is vital to accelerating our understanding of this disease and helps inform the next generation of clinical trials. We remain optimistic about the future of Alzheimer’s treatment and prevention, as the scientific landscape continues to diversify and expand." The company said, "While treatment with semaglutide resulted in improvement of Alzheimer’s disease-related biomarkers in both trials, this did not translate into a delay of disease progression." The evoke and evoke+ trials were large-scale, long-term international clinical trials. More than 3,800 people ages 55-85 diagnosed with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease, (referred to as stage 3 and 4 of Alzheimer’s disease), were enrolled. "These results will help us refine our understanding of this class of drugs," said [Maria C. Carrillo, Ph.D.](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4565580-1&h=1511734777&u=https%3A%2F%2Fwww.alz.org%2Fpress%2Fspokespeople%2Fmaria_c_carrillo_ph_d&a=Maria+C.+Carrillo%2C+Ph.D.), Alzheimer’s Association chief science officer and medical affairs lead. "Though this semaglutide pill did not help against Alzheimer’s, the field will continue to investigate this class of drugs, as they may act differently. And, the Alzheimer’s Association remains a fierce leader for this type of innovative research, and we believe it’s critical to continue investigating diverse approaches to treatment and prevention." The Alzheimer’s treatment pipeline is robust and full of hope. An annual evaluation of the drug development pipeline published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions in early 2025, shows there are 182 active clinical trials evaluating 138 novel drugs. The Alzheimer’s Association, through its "Part the Cloud" program, provides strategic funding to advance promising investigational Alzheimer’s therapies into clinical trials. The treatment targets are varied, which is important given the growing consensus that effective treatment and prevention of Alzheimer’s is likely to be a personalized combination of multiple interventions. For people living with early Alzheimer’s, approved treatments are available. We urge individuals to talk to their doctor about these options. Individuals can also talk to their doctor about participating in clinical trials, or visit the Alzheimer’s Association’s TrialMatch for more information. The Association appreciates these topline results and looks forward to hearing a deeper dive into the data at the Clinical Trials in Alzheimer’s Disease (CTAD) meeting in December. About the Alzheimer’s AssociationThe Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer’s and all other dementia®. Visit [alz.org](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4565580-1&h=4161581990&u=http%3A%2F%2Fwww.alz.org%2F&a=alz.org) or call 800.272.3900. [Source link ](https://www.prnasia.com/story/archive/4832028_AE32028_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/cognizant-doubles-down-on-synapse-commitment-with-new-target-to-reach-two-million-by-2030/) ## Cognizant Doubles Down on Synapse Commitment with New Target to Reach Two Million by 2030 Launched in 2023, Cognizant’s Synapse skilling initiative has outpaced its original goal… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - December 4, 2025 [](https://thailandbusinessnews.net/press-release/protecthealth-strengthens-governance-and-service-continuity-with-iso-22301-bcms-certification/) ![PROTECTHEALTH STRENGTHENS GOVERNANCE AND SERVICE CONTINUITY WITH ISO 22301 BCMS CERTIFICATION](https://i0.wp.com/mma.prnasia.com/media2/2924570/HIGH_RES_PICTURE_BCMS.jpg?resize=260%2C140&ssl=1 "PROTECTHEALTH STRENGTHENS GOVERNANCE AND SERVICE CONTINUITY WITH ISO 22301 BCMS CERTIFICATION") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## PROTECTHEALTH STRENGTHENS GOVERNANCE AND SERVICE CONTINUITY WITH ISO 22301 BCMS CERTIFICATION CYBERJAYA, Malaysia, March 4, 2026 /PRNewswire/ — ProtectHealth Corporation Sdn. Bhd. has… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - March 4, 2026 [](https://thailandbusinessnews.net/press-release/over-half-of-3pl-providers-to-invest-in-predictive-maintenance-and-iot-intelligence-by-2025/) ## Over Half of 3PL Providers to Invest in Predictive Maintenance and IoT Intelligence by 2025 ABI Research survey reveals how third-party logistics firms are prioritizing condition monitoring,… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - December 4, 2025 ##### Most Read - [![Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") [Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") - [![Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/MODERN_MEADOW_LOGO_BLACK_PNG_Logo.jpg?fit=597%2C138&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") [Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") - [![IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") [IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") - [![DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") [DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") - [![Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") [Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") - [![MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") [MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/dbs-gathers-global-leaders-at-inaugural-asia-future-forward-conference-as-ai-rewrites-the-world/) ## DBS Gathers Global Leaders At Inaugural Asia Future Forward Conference As AI Rewrites The World Shou Chew, Lip-Bu Tan, Hock Tan and Jenny Johnson among influential figures… [](https://thailandbusinessnews.net/press-release/midea-showcases-breakthrough-cooling-technologies-for-high-density-ai-data-centers-at-data-center-world-asia-2026/) ![Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026](https://i0.wp.com/mmx.prnasia.com/media/MS1999346/20260929231123EDT_image_1.jpg?resize=260%2C140&ssl=1 "Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026") ## Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026 SINGAPORE, Oct. 2, 2026 /PRNewswire/ — The Asia Data Centre World 2026… [](https://thailandbusinessnews.net/press-release/registration-opens-for-the-2026-eye-level-math-olympiad/) ![Registration Opens for the 2026 Eye Level Math Olympiad](https://i0.wp.com/mmx.prnasia.com/media/MS2000596/20261001022140EDT_image_1.jpg?resize=260%2C140&ssl=1 "Registration Opens for the 2026 Eye Level Math Olympiad") ## Registration Opens for the 2026 Eye Level Math Olympiad SEOUL, South Korea, Oct. 2, 2026 /PRNewswire/ — Eye Level has opened… [](https://thailandbusinessnews.net/press-release/curaleaf-international-secures-australian-first-with-tga-registered-liquid-medical-cannabis-inhalation-device-and-extends-availability-to-new-zealand/) ![Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand](https://i0.wp.com/mmx.prnasia.com/media/MS1612515/Curaleaf-International-Logo.jpg?resize=260%2C140&ssl=1 "Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand") ## Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand LONDON, Oct. 2, 2026 /PRNewswire/ — Curaleaf International, part of Curaleaf…